Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Mollenhauer

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Nucleic Acids Research|September 25, 2014
SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repressionMorten Frier Gjerstorff, Mette Marie Relster, Katrine Buch Viden Greve, et al.
Genes, Chromosomes & Cancer|September 28, 2002
The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancerJan Mollenhauer, Hanna Müller, Gaby Kollender, et al.
Journal of Neuro-Oncology|April 12, 2016
Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid culturesBo Halle, Mads Thomassen, Ranga Venkatesan, et al.
Genes, Chromosomes & Cancer|January 21, 2004
Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesisJan Mollenhauer, Burkhard Helmke, Daniel Medina, et al.
The Journal of Biological Chemistry|September 10, 2004
Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domainsFloris J Bikker, Antoon J M Ligtenberg, Caroline End, et al.
The American Journal of Pathology|May 26, 2007
Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer riskAnneke C Blackburn, Linda Z Hill, Amy L Roberts, et al.
Oncogene|February 14, 2019
CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3Ines Block, Carolin Müller, Daniel Sdogati, et al.
European Journal of Immunology|February 4, 2009
DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligandsCaroline End, Floris Bikker, Marcus Renner, et al.
Gastroenterology|November 7, 2007
DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's diseaseMarcus Renner, Gaby Bergmann, Inge Krebs, et al.
Human Mutation|October 16, 2009
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activitySandrine Tchatchou, Angela Riedel, Stefan Lyer, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Nucleic Acids Research|September 25, 2014
SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repressionMorten Frier Gjerstorff, Mette Marie Relster, Katrine Buch Viden Greve, et al.
Genes, Chromosomes & Cancer|September 28, 2002
The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancerJan Mollenhauer, Hanna Müller, Gaby Kollender, et al.
Journal of Neuro-Oncology|April 12, 2016
Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid culturesBo Halle, Mads Thomassen, Ranga Venkatesan, et al.
Genes, Chromosomes & Cancer|January 21, 2004
Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesisJan Mollenhauer, Burkhard Helmke, Daniel Medina, et al.
The Journal of Biological Chemistry|September 10, 2004
Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domainsFloris J Bikker, Antoon J M Ligtenberg, Caroline End, et al.
The American Journal of Pathology|May 26, 2007
Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer riskAnneke C Blackburn, Linda Z Hill, Amy L Roberts, et al.
Oncogene|February 14, 2019
CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3Ines Block, Carolin Müller, Daniel Sdogati, et al.
European Journal of Immunology|February 4, 2009
DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligandsCaroline End, Floris Bikker, Marcus Renner, et al.
Gastroenterology|November 7, 2007
DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's diseaseMarcus Renner, Gaby Bergmann, Inge Krebs, et al.
Human Mutation|October 16, 2009
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activitySandrine Tchatchou, Angela Riedel, Stefan Lyer, et al.
Pageof 8